Considering the results of both TIMER and HPA databases, monogenic pan-cancer analysis of CCBL2 expression (data from HPA) was performed, and the results indicated that apart from BC, low expression of CCBL2 was associated with poor prognosis of renal, ovarian and head and neck cancers (p<0.0010). This evidence concerns the gene KYAT3 and breast cancer.